Understanding Developability Assessment of Small Molecules

3/10/2020 08:50 - 09:25

  • Why solubility, stability and delivery is imp during lead optimization and its impact of selection of dev candidates
  • Impact of strong interface/collaboration with chemist and pharmacokinetics during NCE selection
  • Speed to clinic with right biopharm properties

Please note that this will be a remote presentation

Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling , Novartis Institutes for BioMedical Research